NPA: Consumer Reports story is ‘an attack on dietary supplements’
WASHINGTON The Natural Products Association on Wednesday challenged a Consumer Reports report in the September 2010 issue around dietary supplements as “an attack on dietary supplements — including a call for additional regulation of the industry — that presents a far from balanced and accurate representation of the industry or the laws that regulate it.”
Many of the products mentioned in the report, the NPA added, aren’t even dietary supplements but adulterated drugs being sold in violation of standing regulation.
The NPA also questioned the data Consumer Reports cited to suggest the dietary supplement industry suffers from inadequate quality controls. “In actuality, evidence from the government suggests the contrary,” the association stated in a press release. “Earlier this year, the [U.S.] Government Accountability Office tested a number of products finding only trace amounts of contaminants, leading the FDA to testify before Congress that ‘we do not believe these levels represent a significant risk to health.’”
Fungi-Nail pen brush applicator drives up Kramer’s sales
MIAMI Kramer Consumer Healthcare recently pegged its first-half sales increases of 38% this year on the success of its Fungi-Nail pen brush applicator launch.
According to Clarissa Sanchez, Fungi-Nail product manager, the new pen brush applicator is outselling Kramer’s 1 oz. SKU by almost two to one in accounts with distribution.
“What has impressed us most is that there has been no cannibalization — our 1 oz. SKU has exhibited strong growth at the same time the pen sales have exploded,” Sanchez said. “What has impressed our retail partners is that their specialty nail fungus segment growth is exploding behind the pen.”
According to Sanchez, one national drug chain grew its sales in the specialty footcare category by more than 40% in dollar sales in the two months following the pen’s launch.
Actavis to reintroduce FeverAll
MORRISTOWN, N.J. Actavis on Tuesday announced the reintroduction of its FeverAll acetaminophen suppositories to retail following the completion of updates to the company’s manufacturing facility.
The brand will be marketed in publications read by new parents and healthcare professionals, the company stated.